With underlying earnings growth of 7%, chemist owner and supplier EBOS Group is tapping healthy conditions in the sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results